OS Therapies Inc. Files 8-K on Financials
Ticker: OSTX · Form: 8-K · Filed: Aug 19, 2025 · CIK: 1795091
| Field | Detail |
|---|---|
| Company | Os Therapies Inc (OSTX) |
| Form Type | 8-K |
| Filed Date | Aug 19, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, results-of-operations
TL;DR
OS Therapies filed an 8-K on Aug 19, 2025, detailing financial results. Check it out.
AI Summary
OS Therapies Inc. filed an 8-K on August 19, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the company incorporated in Delaware and headquartered in Grasonville, Maryland.
Why It Matters
This 8-K filing provides an update on OS Therapies Inc.'s financial performance and condition, which is crucial for investors to assess the company's stability and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting financial condition and results of operations, with no immediate significant events indicated.
Key Players & Entities
- OS Therapies Inc. (company) — Registrant
- August 19, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Grasonville, Maryland (location) — Address of Principal Executive Offices
- 410-297-7793 (phone_number) — Registrant's telephone number
FAQ
What specific financial information is being reported in this 8-K?
This 8-K reports on the 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was the earliest event reported in this filing?
The earliest event reported was on August 19, 2025.
Where is OS Therapies Inc. incorporated?
OS Therapies Inc. is incorporated in Delaware.
What is the principal executive office address for OS Therapies Inc.?
The principal executive office is located at 115 Pullman Crossing Road, Suite 103, Grasonville, Maryland 21638.
What is the IRS Employer Identification Number for OS Therapies Inc.?
The IRS Employer Identification Number for OS Therapies Inc. is 82-5118368.
Filing Stats: 523 words · 2 min read · ~2 pages · Grade level 11.5 · Accepted 2025-08-19 06:50:35
Key Financial Figures
- $0.001 — ch Registered Common Stock, par value $0.001 per share OSTX NYSE American Indi
Filing Documents
- ea0253711-8k_ostherap.htm (8-K) — 27KB
- ea025371101ex99-1_ostherap.htm (EX-99.1) — 33KB
- 0001213900-25-078152.txt ( ) — 232KB
- ostx-20250819.xsd (EX-101.SCH) — 3KB
- ostx-20250819_lab.xml (EX-101.LAB) — 33KB
- ostx-20250819_pre.xml (EX-101.PRE) — 22KB
- ea0253711-8k_ostherap_htm.xml (XML) — 4KB
02. Results of Operations and Financial
Item 2.02. Results of Operations and Financial Condition. On August 19, 2025, OS Therapies Incorporated, a clinical-stage cancer immunotherapy and ADC biotechnology company, issued a press release announcing its financial results for the quarter ended June 30, 2025 and providing a business update. A copy of the press release is furnished with this report as Exhibit 99.1. Such information, including Exhibit 99.1 attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press Release issued by OS Therapies Incorporated on August 19, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. OS THERAPIES INCORPORATED Dated: August 19, 2025 By: /s/ Paul A. Romness, MPH Name: Paul A. Romness, MPH Title: President and Chief Executive Officer 2